Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer
BURSTEIN, Harold J, YAN SUN, ABBAS, Richat, POWELL, Christine, TURNBULL, Kathleen, VERMETTE, Jennifer, ZACHARCHUK, Charles, BADWE, Rajendra, DIRIX, Luc Y, ZEFEI JIANG, PARIDAENS, Robert, TAN, Antoinette R, AWADA, Ahmad, RANADE, Anantbhushan, SHUNCHANG JIAO, SCHWARTZ, Gary
Published in Journal of clinical oncology (10.03.2010)
Published in Journal of clinical oncology (10.03.2010)
Get full text
Journal Article
Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer
SEQUIST, Lecia V, BESSE, Benjamin, ANANTHAKRISHNAN, Revathi, QUINN, Susan, SORIA, Jean-Charles, LYNCH, Thomas J, MILLER, Vincent A, WONG, Kwok K, GITLITZ, Barbara, EATON, Keith, ZACHARCHUK, Charles, FREYMAN, Amy, POWELL, Christine
Published in Journal of clinical oncology (20.06.2010)
Published in Journal of clinical oncology (20.06.2010)
Get full text
Journal Article
A randomized phase 1 pharmacokinetic trial comparing the potential biosimilar PF‐05280014 with trastuzumab in healthy volunteers (REFLECTIONS B327‐01)
Yin, Donghua, Barker, Kerry B., Li, Ruifeng, Meng, Xu, Reich, Steven D., Ricart, Alejandro D., Rudin, Dan, Taylor, Carrie T., Zacharchuk, Charles M., Hansson, Arne G.
Published in British journal of clinical pharmacology (01.12.2014)
Published in British journal of clinical pharmacology (01.12.2014)
Get full text
Journal Article
Phase I Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors
ERLICHMAN, Charles, HIDALGO, Manuel, BONI, Joseph P, MARTINS, Patricia, QUINN, Susan E, ZACHARCHUK, Charles, AMORUSI, Peter, ADJEI, Alex A, ROWINSKY, Eric K
Published in Journal of clinical oncology (20.05.2006)
Published in Journal of clinical oncology (20.05.2006)
Get full text
Journal Article
Evaluating imbalances of adverse events during biosimilar development
Vana, Alicia M., Freyman, Amy W., Reich, Steven D., Yin, Donghua, Li, Ruifeng, Anderson, Scott, Jacobs, Ira A., Zacharchuk, Charles M., Ewesuedo, Reginald
Published in mAbs (03.07.2016)
Published in mAbs (03.07.2016)
Get full text
Journal Article
Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy
Coughlin, Christina M, Johnston, Daniel S, Strahs, Andrew, Burczynski, Michael E, Bacus, Sarah, Hill, Jason, Feingold, Jay M, Zacharchuk, Charles, Berkenblit, Anna
Published in Breast cancer research and treatment (01.11.2010)
Published in Breast cancer research and treatment (01.11.2010)
Get full text
Journal Article
A Phase I Study of EKB-569 in Combination with Capecitabine in Patients with Advanced Colorectal Cancer
LAHERU, Dan, CROGHAN, Gary, ABBAS, Richat, MARTINS, Patricia, ZACHARCHUK, Charles, HIDALGO, Manuel, BUKOWSKI, Ronald, RUDEK, Michelle, MESSERSMITH, Wells, ERLICHMAN, Charles, PELLEY, Robert, JIMENO, Antonio, DONEHOWER, Ross, BONI, Joseph
Published in Clinical cancer research (01.09.2008)
Published in Clinical cancer research (01.09.2008)
Get full text
Journal Article
Phase I Pharmacokinetic/Pharmacodynamic Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Combination with Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in First-Line Treatment of Patients with Metastatic Colorectal Cancer
Folprecht, Gunnar, Tabernero, Josep, Köhne, Claus-Henning, Zacharchuk, Charles, Paz-Ares, Luis, Rojo, Federico, Quinn, Susan, Casado, Esther, Salazar, Ramon, Abbas, Richat, Lejeune, Chantal, Marimón, Irene, Andreu, Jordi, Ubbelohde, Ulrike, Cortes-Funes, Hernan, Baselga, Jose
Published in Clinical cancer research (01.01.2008)
Published in Clinical cancer research (01.01.2008)
Get full text
Journal Article
Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis
Lenczowski, Joi M., Domínguez, Lourdes, Eder, Astrid M., King, Leslie B., Zacharchuk, Charles M., Ashwell, Jonathan D.
Published in Molecular and Cellular Biology (01.01.1997)
Published in Molecular and Cellular Biology (01.01.1997)
Get full text
Journal Article
PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study
Pegram, Mark D, Bondarenko, Igor, Zorzetto, Marina Moreira Costa, Hingmire, Sachin, Iwase, Hirotaka, Krivorotko, Petr V, Lee, Keun Seok, Li, Rubi K, Pikiel, Joanna, Aggarwal, Rajesh, Ewesuedo, Reginald, Freyman, Amy, Li, Ray, Vana, Alicia, Yin, Donghua, Zacharchuk, Charles, Tan-Chiu, Elizabeth
Published in British journal of cancer (01.01.2019)
Published in British journal of cancer (01.01.2019)
Get full text
Journal Article
Abstract OT3-1-02: A Phase 3 randomized, double-blind trial comparing PF-05280014 + docetaxel and carboplatin vs. trastuzumab + docetaxel and carboplatin for neoadjuvant treatment of operable HER2+ breast cancer
Jacobs, Ira, Coiro, Jennifer, Hilton, Fiona, Orazem, John, Abbas, Richat, Zacharchuk, Charles
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Get full text
Journal Article